SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-039167
Filing Date
2019-10-31
Accepted
2019-10-31 16:34:05
Documents
3
Period of Report
2019-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlo-8k_20191031.htm 8-K 28584
2 EX-99.1 mnlo-ex991_9.htm EX-99.1 113181
3 GRAPHIC gmchnyq0n1k5000001.jpg GRAPHIC 3091
  Complete submission text file 0001564590-19-039167.txt   147493
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 191184056
SIC: 2834 Pharmaceutical Preparations